350 руб
Журнал «Технологии живых систем» №4 за 2015 г.
Статья в номере:
Кислый и основной факторы роста фибробластов и канцерогенез. Ч. 1. Механизм действия, ангиогенные и апоптотические эффекты
Ключевые слова: фактор роста фибробластов-1 фактор роста фибробластов-2 рак молочной железы рак простаты остеосаркома
Авторы:
Ольга Ивановна Костылева - к.м.н., ст. науч. сотрудник, лаборатория клинической биохимии, ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России (Москва). Е-mail: ok_olga68@mail.ru Евгения Александровна Тен - аспирант, кафедра клинической биохимии и лабораторной диагностики, Московский государственный медико-стоматологический университет МГМСУ им. А.И. Евдокимова Минздрава России Николай Евгеньевич Кушлинский - д.м.н., профессор, чл.-корр. РАН, зав. лабораторией клинической биохимии, ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России
Аннотация:
В обзоре продемонстрированы разнонаправленные данные о взаимосвязи между экспрессией кислого (ФРФ-1) и основного (ФРФ-2) факторов роста фибробластов.
Страницы: 4-16
Список источников

 

  1. ZhengY.H., Su K., Jian Y.T. et al. Basic fibroblast growth factor enhances osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells in coral scaffold constructs // J. Tissue Eng. Regen. Med. 2011. V. 5. № 5. P. 540 - 550.
  2. Yang C., Liu Y., Li C., Zhang B. Repair of mandibular defects by bone marrow stromal cells expressing the basic fibroblast growth factor transgene combined with multi-pore mineralized Bio-Oss // Mol. Med. Rep. 2013. V. 7. № 1. P. 99 - 104.
  3. Su X., Bao G., Kang H.Effects of basic fibroblast growth factor on bone marrow mesenchymal stem cell differentiation into temporomandibular joint disc cells // Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012. V. 29. № 4. P. 732 - 736.
  4. Yamachika E., Tsujigiwa H., Matsubara M. et al. Basic fibroblast growth factor supports expansion of mouse compact bone-derived mesenchymal stem cells (MSCs) and regeneration of bone from MSC in vivo // J. Mol. Histol. 2012. V. 43. № 2. P. 223 - 233.
  5. Visser R., Arrabal P.M., Santos-Ruiz L. et al. Basic fibroblast growth factor enhances the osteogenic differentiation induced by bone morphogenetic protein-6 in vitro and in vivo // Cytokine. 2012. V. 58. № 1. P. 27 - 33.
  6. Matsumoto G., Hoshino J., Kinoshita Y. et al. Alveolar bone regeneration using poly-(lactic acid-co-glycolic acid-co-epsilon-caprolactone) porous membrane with collagen sponge containing basic fibroblast growth factor: an experimental study in the dog // J. Biomater. 2012. V. 27. № 4. P. 485 - 493.
  7. Mostafa N.Z., Fitzsimmons R., Major P.W. et al. Osteogenic differentiation of human mesenchymal stem cells cultured with dexamethasone, vitamin D3, basic fibroblast growth factor, and bone morphogenetic protein-2 // Connect Tissue Res. 2012. V. 53. № 2. P. 117 - 131.
  8. Tsuji K., Noda M.Transient suppression of core-binding factor alpha 1 expression by basic fibroblast growth factor in rat osteoblast-like osteosarcoma ROS17/2.8 cells // J. Bone Miner. Metab. 2001. V. 19. № 4. P. 213 - 219.
  9. Bodo M., Lilli C., Bellucci C. et al. Basic fibroblast growth factor autocrine loop controls human osteosarcoma phenotyping and differentiation // Mol. Med. 2002. V. 8. № 7. P. 393 - 404.
  10. Powers C.J., McLeskey S.W., Wellstein A. Fibroblast growth factors, their receptors and signaling // Endocr. Relat. Cancer. 2000. V. 7. № 3. P. 165 - 197.
  11. Kwabi-Addo B., Ozen M., Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer // Endocr. Relat. Cancer. 2004. V. 11. № 4. P. 709 - 724.
  12. Turner N., Grose R.Fibroblast growth factor signalling: from development to cancer // Nat. Rev. Cancer. 2010. V. 10. № 2. P. 116 - 129.
  13. Wesley U.V., McGroarty M., Homoyouni A. Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway // Cancer Res. 2005. V. 65. № 4. P. 1325 - 1334.
  14. Presta M., Dell\'Era P., Mitola S. et al.Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis // Cytokine Growth Factor Rev. 2005. V. 16. № 2. P. 159 -178.
  15. Efthimiadou A., Asimakopoulos B., Nikolettos N. et al. Angiogenic effect of intramuscular administration of basic and acidic fibroblast growth factor on skeletal muscles and influence of exercise on muscle angiogenesis // Br. J. Sports Med. 2006. V. 40. № 1. P. 35 ? 39, discussion 35-9.
  16. Pepper M.S., Ferrara N., Orci L., Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro // Biochem. Biophys. Res. Commun. 1992. V. 189. № 2. P. 824 - 831.
  17. Casanovas O., Hicklin D.J., Bergers G., Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors // Cancer Cell. 2005. V. 8. № 4. P. 299 - 309.
  18. Chen G.L., Lin H.B., Wu X.W. et al. The correlation between the level of serum VEGF and bFGF with metastasis and prognosis of osteosarcoma // Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011. V. 27. № 12. P. 1343 - 1345.
  19. Chen Z., Chen Q.X., Hou Z.Y. et al. Clinical predictive value of serum angiogenic factor in patients with osteosarcoma // Asian Pac. J. Cancer Prev. 2012. V. 13. № 9. P. 4823 - 4826.
  20. Burger R.A.Overview of anti-angiogenic agents in development for ovarian cancer // Gynecol. Oncol. 2011. V. 121. № 1. P. 230 - 238.
  21. Murai N., Ueba T., Takahashi J.A. et al. Apoptosis of human glioma cells in vitro and in vivo induced by a neutralizing antibody against human basic fibroblast growth factor // J. Neurosurg. 1996. V. 85. № 6. P. 1072 - 1077.
  22. Konig T., Menzel S., Lynen L. et al.Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis // Leukemia. 1997. V. 11. № 2. P. 258 - 265.
  23. Wang Q., Maloof P., Wang H. et al. Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells // Exp. Cell Res. 1998. V. 238. № 1. P. 177 - 187.
  24. Wan X., Nass P., Duncan M.D., Harmon J.W. Acidic fibroblast growth factor overexpression partially protects 3T3 fibroblasts from apoptosis induced by synthetic retinoid CD437 // J. Mol. Med. (Berl). 2001. V. 79. № 2-3. P. 143 - 148.
  25. Ramos C., Montano M., Becerril C. et al. Acidic fibroblast growth factor decreases alpha-smooth muscle actin expression and induces apoptosis in human normal lung fibroblasts // Am. J. Physiol. Lung Cell Mol. Physiol. 2006. V. 291. № 5. P. 871 - 879.
  26. Fu X.B., Li X.K., Wang T. et al. Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after cancelling of its mitogenic activity // World J. Gastroenterol. 2004. V. 10. № 24. P. 3590 - 3596.
  27. Raju R., Palapetta S.M., Sandhya V.K. et al. A Network Map of FGF-1/FGFR Signaling System // J. Signal. Transduct. 2014. V. 2014:962962.doi: 10.1155/2014/962962.
  28. Jaye M., Howk R., Burgess W. et al. Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization // Science. 1986. V. 233. № 4763. P. 541 - 545.
  29. Imamura T., Engleka K., Zhan X. et al. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence // Science. 1990. V. 249. № 4976. P. 1567 - 1570.
  30. Sano H., Forough R., Maier J.A. et al. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints // J. Cell Biol. 1990. V. 110.  № 4. Р. 1417 - 1426.
  31. Speir E., Sasse J., Shrivastav S., Casscells W. Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells // J. Cell Physiol. 1991. V. 147. № 2. P. 362 - 373.
  32. Wiedlocha A., Falnes P.O., Madshus I.H. et al. Dual mode of signal transduction by externally added acidic fibroblast growth factor // Cell. 1994. V. 76. № 6. P. 1039 - 1051.
  33. Luo Y., Gabriel J.L., Wang F. et al. Molecular modeling and deletion mutagenesis implicate the nuclear translocation sequence in structural integrity of fibroblast growth factor-1 // J. Biol. Chem. 1996. V. 271. № 43. P. 26876 - 26883.
  34. Kamura S., Matsumoto Y., Fukushi J.I. et al. Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing\'s sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway // Br. J. Cancer. 2010. V. 103. № 3. P. 370 - 381.
  35. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy // Nat. Rev. Drug Discov. 2009. V. 8. № 3. P. 235 - 253.
  36. Florkiewicz R.Z., Sommer A. Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons // Proc. Natl. Acad. Sci. USA. 1989. V. 86. № 11. P. 3978 - 3981.
  37. Touriol C., Bornes S., Bonnal S et al. Generation of protein isoform diversity by alternative initiation of translation at non-AUG codons // Biol. Cell. 2003. V. 95. № 3-4. P. 169 - 178.
  38. Bugler B., Caizergues-Ferrer M., Bouche G. et al. Detection and localization of a class of proteins immunologically related to a 100-kDa nucleolar protein // Eur. J. Biochem. 1982. V. 128. № 2-3. P. 475 - 480.
  39. Bohlen P., Esch F., Baird A. et al. Human brain fibroblast growth factor. Isolation and partial chemical characterization // FEBS Lett. 1985. V. 185. № 1. P. 177 - 181.
  40. Gimenez-Gallego G., Rodkey J., Bennett C. et al. Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies // Science. 1985. V. 230. № 4732. P. 1385 - 1388.
  41. Kozak M.Influences of mRNA secondary structure on initiation by eukaryotic ribosomes // Proc. Natl. Acad. Sci. USA. 1986. V. 83. № 9. P. 2850 - 2854.
  42. Olsen S.K., Garbi M., Zampieri N. et al. Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs // J. Biol. Chem. 2003. V. 278. № 36. P. 34226 - 34236.
  43. Yu P.J., Ferrari G., Galloway A.C. et al. Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age // J. Cell Biochem. 2007. V. 100. № 5. P. 1100 - 1108.
  44. Bugler B., Amalric F., Prats H. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor // Mol. Cell Biol. 1991. V. 11. № 1. P. 573 - 577.
  45. Arakawa T., Hsu Y.R., Schiffer S.G. et al. Characterization of a cysteine-free analog of recombinant human basic fibroblast growth factor // Biochem. Biophys. Res. Commun. 1989. V. 161. № 1. P. 335 - 341.
  46. Carpenter G., Liao H.J. Trafficking of receptor tyrosine kinases to the nucleus // Exp. Cell Res. 2009. V. 315. № 9. P. 1556 - 1566.
  47. Claus P., Doring F., Gringel S. et al. Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein // J. Biol. Chem. 2003. V. 278. № 1. P. 479 - 485.
  48. Liao S., Bodmer J., Pietras D. et al. Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease // Dev. Dyn. 2009. V. 238. № 2. P. 249 - 264.
  49. Bouche G., Gas N., Prats H. et al. Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0-G1 transition // Proc. Natl. Acad. Sci. USA. 1987. V. 84. № 19. P. 6770 - 6774.
  50. DiMario J., Buffinger N., Yamada S., Strohman R.C. Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle // Science. 1989. V. 244. № 4905. P. 688 - 690.
  51. Safran A., Avivi A., Orr-Urtereger A. et al. The murine flg gene encodes a receptor for fibroblast growth factor // Oncogene. 1990. V. 5. № 5. P. 635 - 643.
  52. Renko M., Quarto N., Morimoto T., Rifkin D.B. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species // J. Cell Physiol. 1990. V. 144. № 1. P. 108 - 114.
  53. McNeil P.L., Muthukrishnan L., Warder E., D\'Amore P.A. Growth factors are released by mechanically wounded endothelial cells // J. Cell Biol. 1989. V. 109. № 2. P. 811 - 822.
  54. Jackson A., Friedman S., Zhan X. et al. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells // Proc. Natl. Acad. Sci. USA. 1992. V. 89. № 22. P. 10691 - 10695.
  55. Jackson A., Tarantini F., Gamble S. et al. The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues // J. Biol. Chem. 1995. V. 270. № 1. P. 33 - 36.
  56. Mignatti P., Morimoto T., Rifkin D.B. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner // Proc. Natl. Acad. Sci. USA. 1991.  V. 88. № 24. P. 11007 - 11011.
  57. Klagsbrun M., Smith S., Sullivan R. et al. Multiple forms of basic fibroblast growth factor: amino-terminal cleavages by tumor cell- and brain cell-derived acid proteinases // Proc. Natl. Acad. Sci. USA. 1987. V. 84. № 7. P. 1839 - 1843.
  58. Rubartelli A., Cozzolino F., Talio M., Sitia R. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence // EMBO J. 1990. V. 9. № 5. P. 1503 - 1510.
  59. Mills C.D., Nguyen T., Tanga F.Y. et al. Characterization of nerve growth factor-induced mechanical and thermal hypersensitivity in rats // Eur. J. Pain. 2013. V. 17. № 4. P. 469 - 479.
  60. Coleman S.J., Bruce C., Chioni A.M. et al. The ins and outs of fibroblast growth factor receptor signalling // Clin. Sci. (Lond). 2014. V. 127. № 4. P. 217 - 231.
  61. Cheng J.D., Weiner L.M. Tumors and their microenvironments: tilling the soil. Commentary re: A.M. Scottet al., A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer // Clin. Cancer Res. 2003. V. 9. № 5. P. 1590 - 1595, P. 1639 - 1647.
  62. Ramachandran I., Thavathiru E., Ramalingam S. et al. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo // Oncogene. 2012.  V. 31. № 22. P. 2725 - 2737.
  63. Герштейн Е.С., Кушлинский Н.Е. Факторы роста, их рецепторы и нижележащие сигнальные белки: от эксперимента к клинике // Успехи молекулярной онкологии. 2014. №1. С. 27-35.
  64. Skarpen E., Johannessen L.E., Bjerk K. et al.Endocytosed epidermal growth factor (EGF) receptors contribute to the EGF-mediated growth arrest in A431 cells by inducing a sustained increase in p21/CIP1 // Exp. Cell Res. 1998. V. 243. № 1. P. 161 - 172.
  65. Schlessinger J., Plotnikov A.N., Ibrahimi O.A. et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization // Mol. Cell. 2000. V. 6. № 3. P. 743 - 750.
  66. Feige J.J., Bradley J.D., Fryburg K. et al. Differential effects of heparin, fibronectin, and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A // J. Cell Biol. 1989. V. 109. № 6. Pt. 1. P. 3105 - 3114.
  67. Feige J.J., Baird A.Basic fibroblast growth factor is a substrate for protein phosphorylation and is phosphorylated by capillary endothelial cells in culture // Proc. Natl. Acad. Sci. USA. 1989. V. 86. № 9. P. 3174 - 3178.
  68. Katoh M.Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis // Stem Cell Rev. 2007. V. 3. № 1. P. 30 - 38.
  69. Moon R.T., Bowerman B., Boutros M., Perrimon N. The promise and perils of Wnt signaling through beta-catenin // Science. 2002. V. 296. № 5573. P. 1644 - 1646.
  70. Katoh M.Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades // Cancer Biol. Ther. 2006. V. 5. № 9. P. 1059 - 1064.
  71. Ten Berge D., Brugmann S.A., Helms J.A., Nusse R. Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development // Development. 2008. V. 135. № 19. P. 3247 - 3257.
  72. Froeling F.E., Feig C., Chelala C. et al. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-beta-catenin signaling to slow tumor progression // Gastroenterology. 2011. V. 141. № 4. P. 1486 - 1497.
  73. Aleksic T., Chitnis M.M., Perestenko O.V. et al. Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells // Cancer Res. 2010. V. 70. № 16. P. 6412 - 6419.
  74. Ornitz D.M.Regulation of chondrocyte growth and differentiation by fibroblast growth factor receptor 3 // Novartis Found Symp. 2001.  V. 232. P. 63 - 76; discussion 76-80, 272-282.
  75. Katoh M.WNT signaling in stem cell biology and regenerative medicine // Curr. Drug Targets. 2008. V. 9. № 7. P. 565-570.
  76. Yan G., Fukabori Y., McBride G. et al. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy // Mol. Cell Biol. 1993. V. 13. № 8. P. 4513 - 4522.
  77. Giri D., Ropiquet F., Ittmann M. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer // Clin. Cancer Res. 1999. V. 5. № 5. P. 1063 - 1071.
  78. Seghezzi G., Patel S., Ren C.J. et al. Fi­broblast growth factor-2 (FGF-2) in­duces vascular endothelial growth fac­tor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis // J. Cell Biol. 1998. V. 141. № 7. P. 1659 - 1673.